Omega-3 Fatty Acids and Coronary Artery Disease: More Questions Than Answers

Studies show that patients with elevated triglycerides and well-controlled LDL levels under statin therapy still have a significant residual risk of cardiovascular (CV) events. Despite many attempts to reduce triglycerides with different hypolipidemic drugs, no therapeutic option has given satisfact...

Descripción completa

Detalles Bibliográficos
Autores principales: Tadic, Marijana, Sala, Carla, Grassi, Guido, Mancia, Giuseppe, Taddei, Stefano, Rottbauer, Wolfgang, Cuspidi, Cesare
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8201167/
https://www.ncbi.nlm.nih.gov/pubmed/34200081
http://dx.doi.org/10.3390/jcm10112495

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8201167/
https://www.ncbi.nlm.nih.gov/pubmed/34200081
http://dx.doi.org/10.3390/jcm10112495

Ejemplares similares